Synergistic effects of cytosine arabinoside combined with antilymphocyte globulin for suppressing xenograft rejection.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D004357:Drug Synergism; D006041:Goats; D006648:Histocompatibility; D007668:Kidney / Q000473:pathology; D016030:Kidney Transplantation; D009026:Mortality; D013552:Swine; D014181:Transplantation Immunology; D014183:Transplantation, Heterologous; D005719:gamma-Globulins / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D005719:gamma-Globulins; D003561:Cytarabine